Alternative therapeutics to control antimicrobial resistance: a general perspective

B Singha, V Singh, V Soni - Frontiers in Drug Discovery, 2024 - frontiersin.org
Antimicrobial Resistance (AMR) is a critical global health challenge, and in this review
article, we examine the limitations of traditional therapeutic methods and the emerging role …

Key challenges in TB drug discovery: A perspective

BB Shaik, R Karpoormath - Bioorganic & Medicinal Chemistry Letters, 2024 - Elsevier
Over the past 2000 years, tuberculosis (TB) has been responsible for more deaths than any
other infectious disease. In recent years, there has been a recovery of research and …

Ajoene: a natural compound with enhanced antimycobacterial and antibiofilm properties mediated by efflux pump modulation and ROS generation against M …

A Sarangi, BS Das, I Pahuja, S Ojha, V Singh… - Archives of …, 2024 - Springer
Tuberculosis (TB) continues to be a primary worldwide health concern due to relatively
ineffective treatments. The prolonged duration of conventional antibiotic therapy warrants …

Discovery of acetohydroxyacid synthase inhibitors as anti-tuberculosis lead compounds from natural products

Y Niu, Z Wu, Q Hu, Y Wu, Q Jiang, X Yang - Bioorganic & Medicinal …, 2025 - Elsevier
Acetohydroxy acid synthase (AHAS) is a key enzyme that catalyzes the synthesis of
branched-chain amino acids, which is indispensable for the survival and growth of …

Antimicrobial Resistance and Factors: An Introduction

V Soni, AB Doltrario, EH Rosenn, S Das… - … Resistance: Factors to …, 2024 - Springer
Antimicrobial resistance (AMR) stands as a parallel pandemic, growing at an astonishing
rate. Given the failing efficacy of traditional therapeutic approaches, it becomes imperative to …

Antibiotic Resistance in Mycobacterium Tuberculosis and Non-Tuberculous Mycobacteria

R Wamalwa, B Guyah, N Shaviya - African Journal of Empirical Research, 2024 - ajol.info
Mycobacterium tuberculosis (MTB) and non-tuberculous mycobacteria (NTM) antibiotic
resistance presents an important challenge to the treatment of mycobacterial infections. The …